[2P-0516] Establishment of high susceptible model of SARS-CoV2 in CAG promoter-driven hACE2 transgenic mice

^○Masamitsu Asaka¹, Daichi Utsumi¹, Haruhiko Kamada^{2, 3, 4}, Satoshi Nagata³, Yutaka Nakachi⁵, Tomokazu Yamaguchi⁶, Koji Kobiyama⁷, Ken Ishii⁷, Keiji Kuba⁶, Yasuhiro Yasutomi¹ (1.TPRC. NIBIOHN, 2.Lab. of Biopharmaceutical Research, NIBIOHN, 3.Lab. of Antibody Design, NIBIOHN, 4.Global Center for MEI. Osaka Univ., 5.Dep. of Mol. Brain Sci., Grad. Sch. of Med. Sci., Kumamoto Univ., 6.Dep. of Biochemistry and Metabolic Sci., Grad. Sch. of Med., Akita Univ., 7.Division of Vaccine Sci., Dep. of Microbiology and Immunology, The Ins. of Med. Sci., Univ. of Tokyo)

g . Infection / Virus(4 . Animal and Plant Physiology, and Diseases)